Competent Cells Market is expected to reach US$ 5.9 Bn by 2032, with sales revenue expected to regis
By the end of 2022, the Competent Cells Market is anticipated to reach US$ 2.1 billion, growing at a double-digit rate of 11.1% CAGR (2022-2032). By 2032, the market’s sales are projected to be worth $5.9 billion USD. Chemically competent cells held the market’s top spot in terms of product type in 2021, with a shar...
New York United States Agilent Technologies Inc Biotechnology Companies Genescript Biotech Corporation Academic Research Institutes
Source: pharmiweb.com